Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Candesartan and Rosuvastatin Coadministration
NCT02079506Phase 1Completed
- Sponsor
- Alvogen
- Start
- Feb 2014
- Primary completion
- Feb 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of candesartan and rosuvastatin in hypertension (HTN) and hypercholesterolemia, sponsored by Alvogen. Primary endpoints: Area Under the Curve at steady state over dosing interval and Maximum Plasma Concentration at steady state. Started Feb 2014; status: completed.
02
Drugs
candesartanrosuvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02079506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079506.